nodes	percent_of_prediction	percent_of_DWPC	metapath
Alosetron—CYP2C9—Capecitabine—colon cancer	0.164	0.342	CbGbCtD
Alosetron—CYP1A2—Fluorouracil—colon cancer	0.108	0.225	CbGbCtD
Alosetron—CYP2C9—Fluorouracil—colon cancer	0.097	0.203	CbGbCtD
Alosetron—Bilirubin abnormal—Irinotecan—colon cancer	0.0716	0.155	CcSEcCtD
Alosetron—CYP3A4—Irinotecan—colon cancer	0.0588	0.123	CbGbCtD
Alosetron—Blood bilirubin abnormal—Irinotecan—colon cancer	0.0569	0.123	CcSEcCtD
Alosetron—CYP3A4—Vincristine—colon cancer	0.0514	0.107	CbGbCtD
Alosetron—HTR3A—myenteric nerve plexus—colon cancer	0.0404	0.676	CbGeAlD
Alosetron—Colitis ulcerative—Irinotecan—colon cancer	0.0136	0.0294	CcSEcCtD
Alosetron—Proctocolitis—Irinotecan—colon cancer	0.0136	0.0294	CcSEcCtD
Alosetron—Proctitis—Fluorouracil—colon cancer	0.0134	0.0291	CcSEcCtD
Alosetron—Colitis ischaemic—Irinotecan—colon cancer	0.0117	0.0253	CcSEcCtD
Alosetron—Balance disorder—Fluorouracil—colon cancer	0.006	0.013	CcSEcCtD
Alosetron—Nail disorder—Fluorouracil—colon cancer	0.00506	0.011	CcSEcCtD
Alosetron—Ileus—Vincristine—colon cancer	0.00497	0.0108	CcSEcCtD
Alosetron—Ileus—Irinotecan—colon cancer	0.00484	0.0105	CcSEcCtD
Alosetron—Balance disorder—Capecitabine—colon cancer	0.00419	0.00909	CcSEcCtD
Alosetron—Cognitive disorder—Methotrexate—colon cancer	0.00395	0.00855	CcSEcCtD
Alosetron—Haemorrhoids—Capecitabine—colon cancer	0.0039	0.00845	CcSEcCtD
Alosetron—Drug interaction—Vincristine—colon cancer	0.00379	0.00822	CcSEcCtD
Alosetron—Tenderness—Fluorouracil—colon cancer	0.00376	0.00815	CcSEcCtD
Alosetron—Bone pain—Vincristine—colon cancer	0.00367	0.00796	CcSEcCtD
Alosetron—Haematoma—Capecitabine—colon cancer	0.00365	0.0079	CcSEcCtD
Alosetron—Ulcer—Irinotecan—colon cancer	0.00362	0.00785	CcSEcCtD
Alosetron—Nail disorder—Capecitabine—colon cancer	0.00354	0.00766	CcSEcCtD
Alosetron—Ulcer—Fluorouracil—colon cancer	0.00347	0.00752	CcSEcCtD
Alosetron—Colitis—Irinotecan—colon cancer	0.00329	0.00713	CcSEcCtD
Alosetron—Ileus—Capecitabine—colon cancer	0.00324	0.00702	CcSEcCtD
Alosetron—Laryngitis—Capecitabine—colon cancer	0.00318	0.00689	CcSEcCtD
Alosetron—Urine output increased—Vincristine—colon cancer	0.00318	0.00689	CcSEcCtD
Alosetron—Photophobia—Fluorouracil—colon cancer	0.00308	0.00667	CcSEcCtD
Alosetron—HTR3A—digestive system—colon cancer	0.00306	0.0512	CbGeAlD
Alosetron—Fungal infection—Capecitabine—colon cancer	0.00297	0.00643	CcSEcCtD
Alosetron—Polyuria—Vincristine—colon cancer	0.00291	0.0063	CcSEcCtD
Alosetron—Extrasystoles—Capecitabine—colon cancer	0.00272	0.0059	CcSEcCtD
Alosetron—Folliculitis—Methotrexate—colon cancer	0.00272	0.00588	CcSEcCtD
Alosetron—Injury—Irinotecan—colon cancer	0.00271	0.00586	CcSEcCtD
Alosetron—Nail disorder—Methotrexate—colon cancer	0.00263	0.0057	CcSEcCtD
Alosetron—Contusion—Capecitabine—colon cancer	0.00263	0.00569	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Capecitabine—colon cancer	0.00256	0.00554	CcSEcCtD
Alosetron—Burning sensation—Methotrexate—colon cancer	0.00246	0.00532	CcSEcCtD
Alosetron—Ulcer—Capecitabine—colon cancer	0.00242	0.00525	CcSEcCtD
Alosetron—Bone pain—Capecitabine—colon cancer	0.00239	0.00519	CcSEcCtD
Alosetron—Blood pressure increased—Capecitabine—colon cancer	0.00229	0.00497	CcSEcCtD
Alosetron—Cramp muscle—Irinotecan—colon cancer	0.00224	0.00485	CcSEcCtD
Alosetron—Fungal infection—Methotrexate—colon cancer	0.00221	0.00479	CcSEcCtD
Alosetron—Colitis—Capecitabine—colon cancer	0.0022	0.00477	CcSEcCtD
Alosetron—Abdominal distension—Irinotecan—colon cancer	0.00216	0.00469	CcSEcCtD
Alosetron—Nasopharyngitis—Fluorouracil—colon cancer	0.00213	0.00461	CcSEcCtD
Alosetron—Urine output increased—Capecitabine—colon cancer	0.00207	0.00449	CcSEcCtD
Alosetron—Upper respiratory tract infection—Irinotecan—colon cancer	0.002	0.00433	CcSEcCtD
Alosetron—Depression—Vincristine—colon cancer	0.00196	0.00425	CcSEcCtD
Alosetron—CYP1A2—renal system—colon cancer	0.00193	0.0322	CbGeAlD
Alosetron—Sleep disorder—Capecitabine—colon cancer	0.00192	0.00417	CcSEcCtD
Alosetron—Upper respiratory tract infection—Fluorouracil—colon cancer	0.00191	0.00414	CcSEcCtD
Alosetron—Musculoskeletal stiffness—Methotrexate—colon cancer	0.0019	0.00412	CcSEcCtD
Alosetron—Polyuria—Capecitabine—colon cancer	0.0019	0.00411	CcSEcCtD
Alosetron—Sweating—Vincristine—colon cancer	0.00189	0.00409	CcSEcCtD
Alosetron—Gastroenteritis—Capecitabine—colon cancer	0.00188	0.00407	CcSEcCtD
Alosetron—Jaundice—Irinotecan—colon cancer	0.00187	0.00405	CcSEcCtD
Alosetron—Sweating—Irinotecan—colon cancer	0.00184	0.00398	CcSEcCtD
Alosetron—Ulcer—Methotrexate—colon cancer	0.0018	0.00391	CcSEcCtD
Alosetron—Urinary tract infection—Fluorouracil—colon cancer	0.00178	0.00387	CcSEcCtD
Alosetron—Hypoaesthesia—Vincristine—colon cancer	0.00176	0.00381	CcSEcCtD
Alosetron—CYP2E1—renal system—colon cancer	0.00173	0.029	CbGeAlD
Alosetron—Haemoglobin—Irinotecan—colon cancer	0.00173	0.00375	CcSEcCtD
Alosetron—Sinusitis—Fluorouracil—colon cancer	0.00172	0.00373	CcSEcCtD
Alosetron—Haemorrhage—Irinotecan—colon cancer	0.00172	0.00373	CcSEcCtD
Alosetron—Cystitis noninfective—Methotrexate—colon cancer	0.00167	0.00361	CcSEcCtD
Alosetron—Haemoglobin—Fluorouracil—colon cancer	0.00166	0.00359	CcSEcCtD
Alosetron—Cystitis—Methotrexate—colon cancer	0.00165	0.00357	CcSEcCtD
Alosetron—Haemorrhage—Fluorouracil—colon cancer	0.00165	0.00357	CcSEcCtD
Alosetron—Hypoaesthesia—Fluorouracil—colon cancer	0.00164	0.00355	CcSEcCtD
Alosetron—CYP1A2—digestive system—colon cancer	0.00158	0.0264	CbGeAlD
Alosetron—Alopecia—Vincristine—colon cancer	0.00156	0.00338	CcSEcCtD
Alosetron—Bladder pain—Methotrexate—colon cancer	0.00154	0.00334	CcSEcCtD
Alosetron—Urine output increased—Methotrexate—colon cancer	0.00154	0.00334	CcSEcCtD
Alosetron—Arrhythmia—Irinotecan—colon cancer	0.00154	0.00333	CcSEcCtD
Alosetron—Alopecia—Irinotecan—colon cancer	0.00152	0.00329	CcSEcCtD
Alosetron—Abdominal pain upper—Capecitabine—colon cancer	0.00152	0.00329	CcSEcCtD
Alosetron—CYP2C9—digestive system—colon cancer	0.0015	0.0251	CbGeAlD
Alosetron—Nasopharyngitis—Capecitabine—colon cancer	0.00149	0.00322	CcSEcCtD
Alosetron—Flatulence—Irinotecan—colon cancer	0.00148	0.0032	CcSEcCtD
Alosetron—Gastritis—Capecitabine—colon cancer	0.00147	0.00319	CcSEcCtD
Alosetron—Arrhythmia—Fluorouracil—colon cancer	0.00147	0.00319	CcSEcCtD
Alosetron—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00147	0.00318	CcSEcCtD
Alosetron—Alopecia—Fluorouracil—colon cancer	0.00146	0.00315	CcSEcCtD
Alosetron—Abdominal distension—Capecitabine—colon cancer	0.00145	0.00314	CcSEcCtD
Alosetron—Muscle spasms—Irinotecan—colon cancer	0.00144	0.00312	CcSEcCtD
Alosetron—CYP2E1—lymphoid tissue—colon cancer	0.00144	0.024	CbGeAlD
Alosetron—CYP2E1—digestive system—colon cancer	0.00142	0.0238	CbGeAlD
Alosetron—Polyuria—Methotrexate—colon cancer	0.00141	0.00306	CcSEcCtD
Alosetron—CYP3A4—renal system—colon cancer	0.00139	0.0233	CbGeAlD
Alosetron—Ill-defined disorder—Irinotecan—colon cancer	0.00139	0.00301	CcSEcCtD
Alosetron—Abdominal discomfort—Capecitabine—colon cancer	0.00138	0.00299	CcSEcCtD
Alosetron—Malaise—Irinotecan—colon cancer	0.00135	0.00293	CcSEcCtD
Alosetron—Upper respiratory tract infection—Capecitabine—colon cancer	0.00134	0.0029	CcSEcCtD
Alosetron—Hypertension—Vincristine—colon cancer	0.00133	0.00288	CcSEcCtD
Alosetron—Myalgia—Vincristine—colon cancer	0.00131	0.00284	CcSEcCtD
Alosetron—Cough—Irinotecan—colon cancer	0.00131	0.00283	CcSEcCtD
Alosetron—Hyperglycaemia—Capecitabine—colon cancer	0.0013	0.00281	CcSEcCtD
Alosetron—Hypertension—Irinotecan—colon cancer	0.00129	0.0028	CcSEcCtD
Alosetron—Depression—Capecitabine—colon cancer	0.00128	0.00277	CcSEcCtD
Alosetron—Discomfort—Irinotecan—colon cancer	0.00126	0.00273	CcSEcCtD
Alosetron—Jaundice—Capecitabine—colon cancer	0.00125	0.00271	CcSEcCtD
Alosetron—Infection—Vincristine—colon cancer	0.00125	0.0027	CcSEcCtD
Alosetron—Urinary tract infection—Capecitabine—colon cancer	0.00125	0.0027	CcSEcCtD
Alosetron—Confusional state—Irinotecan—colon cancer	0.00123	0.00267	CcSEcCtD
Alosetron—Myalgia—Fluorouracil—colon cancer	0.00122	0.00265	CcSEcCtD
Alosetron—Infection—Irinotecan—colon cancer	0.00121	0.00263	CcSEcCtD
Alosetron—Hyperhidrosis—Vincristine—colon cancer	0.00121	0.00263	CcSEcCtD
Alosetron—Discomfort—Fluorouracil—colon cancer	0.00121	0.00261	CcSEcCtD
Alosetron—Hyperhidrosis—Irinotecan—colon cancer	0.00118	0.00256	CcSEcCtD
Alosetron—Confusional state—Fluorouracil—colon cancer	0.00118	0.00256	CcSEcCtD
Alosetron—CYP1A2—liver—colon cancer	0.00118	0.0197	CbGeAlD
Alosetron—Infection—Fluorouracil—colon cancer	0.00116	0.00252	CcSEcCtD
Alosetron—Haemoglobin—Capecitabine—colon cancer	0.00116	0.00251	CcSEcCtD
Alosetron—Haemorrhage—Capecitabine—colon cancer	0.00115	0.00249	CcSEcCtD
Alosetron—Hepatitis—Capecitabine—colon cancer	0.00115	0.00249	CcSEcCtD
Alosetron—Hypoaesthesia—Capecitabine—colon cancer	0.00115	0.00248	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Vincristine—colon cancer	0.00114	0.00248	CcSEcCtD
Alosetron—CYP3A4—digestive system—colon cancer	0.00114	0.0191	CbGeAlD
Alosetron—CYP2C9—liver—colon cancer	0.00112	0.0187	CbGeAlD
Alosetron—Fatigue—Vincristine—colon cancer	0.00108	0.00234	CcSEcCtD
Alosetron—Pain—Vincristine—colon cancer	0.00107	0.00233	CcSEcCtD
Alosetron—Constipation—Vincristine—colon cancer	0.00107	0.00233	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00107	0.00231	CcSEcCtD
Alosetron—CYP2E1—liver—colon cancer	0.00106	0.0177	CbGeAlD
Alosetron—Fatigue—Irinotecan—colon cancer	0.00105	0.00228	CcSEcCtD
Alosetron—Constipation—Irinotecan—colon cancer	0.00105	0.00226	CcSEcCtD
Alosetron—Pain—Irinotecan—colon cancer	0.00105	0.00226	CcSEcCtD
Alosetron—Arrhythmia—Capecitabine—colon cancer	0.00103	0.00223	CcSEcCtD
Alosetron—Abdominal discomfort—Methotrexate—colon cancer	0.00103	0.00222	CcSEcCtD
Alosetron—Alopecia—Capecitabine—colon cancer	0.00102	0.0022	CcSEcCtD
Alosetron—Feeling abnormal—Irinotecan—colon cancer	0.00101	0.00218	CcSEcCtD
Alosetron—Pain—Fluorouracil—colon cancer	0.001	0.00217	CcSEcCtD
Alosetron—Upper respiratory tract infection—Methotrexate—colon cancer	0.000995	0.00216	CcSEcCtD
Alosetron—Flatulence—Capecitabine—colon cancer	0.000988	0.00214	CcSEcCtD
Alosetron—Feeling abnormal—Fluorouracil—colon cancer	0.000965	0.00209	CcSEcCtD
Alosetron—Muscle spasms—Capecitabine—colon cancer	0.000964	0.00209	CcSEcCtD
Alosetron—Depression—Methotrexate—colon cancer	0.000952	0.00206	CcSEcCtD
Alosetron—Tremor—Capecitabine—colon cancer	0.000939	0.00203	CcSEcCtD
Alosetron—Ill-defined disorder—Capecitabine—colon cancer	0.00093	0.00201	CcSEcCtD
Alosetron—Urticaria—Fluorouracil—colon cancer	0.00093	0.00201	CcSEcCtD
Alosetron—Hypersensitivity—Vincristine—colon cancer	0.000925	0.002	CcSEcCtD
Alosetron—Sweating—Methotrexate—colon cancer	0.000915	0.00198	CcSEcCtD
Alosetron—Malaise—Capecitabine—colon cancer	0.000904	0.00196	CcSEcCtD
Alosetron—Hypersensitivity—Irinotecan—colon cancer	0.000901	0.00195	CcSEcCtD
Alosetron—Asthenia—Vincristine—colon cancer	0.0009	0.00195	CcSEcCtD
Alosetron—Asthenia—Irinotecan—colon cancer	0.000877	0.0019	CcSEcCtD
Alosetron—Cough—Capecitabine—colon cancer	0.000875	0.00189	CcSEcCtD
Alosetron—Hypertension—Capecitabine—colon cancer	0.000865	0.00187	CcSEcCtD
Alosetron—Hypersensitivity—Fluorouracil—colon cancer	0.000862	0.00187	CcSEcCtD
Alosetron—Haemoglobin—Methotrexate—colon cancer	0.000861	0.00187	CcSEcCtD
Alosetron—Haemorrhage—Methotrexate—colon cancer	0.000857	0.00186	CcSEcCtD
Alosetron—Hepatitis—Methotrexate—colon cancer	0.000857	0.00186	CcSEcCtD
Alosetron—Myalgia—Capecitabine—colon cancer	0.000853	0.00185	CcSEcCtD
Alosetron—CYP3A4—liver—colon cancer	0.000852	0.0142	CbGeAlD
Alosetron—Anxiety—Capecitabine—colon cancer	0.00085	0.00184	CcSEcCtD
Alosetron—Discomfort—Capecitabine—colon cancer	0.000843	0.00183	CcSEcCtD
Alosetron—Dry mouth—Capecitabine—colon cancer	0.000835	0.00181	CcSEcCtD
Alosetron—Confusional state—Capecitabine—colon cancer	0.000825	0.00179	CcSEcCtD
Alosetron—Infection—Capecitabine—colon cancer	0.000813	0.00176	CcSEcCtD
Alosetron—Vomiting—Vincristine—colon cancer	0.000798	0.00173	CcSEcCtD
Alosetron—Skin disorder—Capecitabine—colon cancer	0.000795	0.00172	CcSEcCtD
Alosetron—Rash—Vincristine—colon cancer	0.000791	0.00171	CcSEcCtD
Alosetron—Hyperhidrosis—Capecitabine—colon cancer	0.000791	0.00171	CcSEcCtD
Alosetron—Dermatitis—Vincristine—colon cancer	0.000791	0.00171	CcSEcCtD
Alosetron—Headache—Vincristine—colon cancer	0.000786	0.0017	CcSEcCtD
Alosetron—Vomiting—Irinotecan—colon cancer	0.000777	0.00168	CcSEcCtD
Alosetron—Rash—Irinotecan—colon cancer	0.000771	0.00167	CcSEcCtD
Alosetron—Dermatitis—Irinotecan—colon cancer	0.00077	0.00167	CcSEcCtD
Alosetron—Headache—Irinotecan—colon cancer	0.000766	0.00166	CcSEcCtD
Alosetron—Alopecia—Methotrexate—colon cancer	0.000757	0.00164	CcSEcCtD
Alosetron—Nausea—Vincristine—colon cancer	0.000745	0.00162	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000745	0.00161	CcSEcCtD
Alosetron—Vomiting—Fluorouracil—colon cancer	0.000744	0.00161	CcSEcCtD
Alosetron—Rash—Fluorouracil—colon cancer	0.000738	0.0016	CcSEcCtD
Alosetron—Dermatitis—Fluorouracil—colon cancer	0.000737	0.0016	CcSEcCtD
Alosetron—Headache—Fluorouracil—colon cancer	0.000733	0.00159	CcSEcCtD
Alosetron—Nausea—Irinotecan—colon cancer	0.000726	0.00157	CcSEcCtD
Alosetron—Fatigue—Capecitabine—colon cancer	0.000705	0.00153	CcSEcCtD
Alosetron—Constipation—Capecitabine—colon cancer	0.0007	0.00152	CcSEcCtD
Alosetron—Pain—Capecitabine—colon cancer	0.0007	0.00152	CcSEcCtD
Alosetron—Nausea—Fluorouracil—colon cancer	0.000695	0.00151	CcSEcCtD
Alosetron—Ill-defined disorder—Methotrexate—colon cancer	0.000692	0.0015	CcSEcCtD
Alosetron—Feeling abnormal—Capecitabine—colon cancer	0.000674	0.00146	CcSEcCtD
Alosetron—Malaise—Methotrexate—colon cancer	0.000673	0.00146	CcSEcCtD
Alosetron—Cough—Methotrexate—colon cancer	0.000651	0.00141	CcSEcCtD
Alosetron—Urticaria—Capecitabine—colon cancer	0.00065	0.00141	CcSEcCtD
Alosetron—Myalgia—Methotrexate—colon cancer	0.000635	0.00138	CcSEcCtD
Alosetron—Discomfort—Methotrexate—colon cancer	0.000628	0.00136	CcSEcCtD
Alosetron—Confusional state—Methotrexate—colon cancer	0.000614	0.00133	CcSEcCtD
Alosetron—Infection—Methotrexate—colon cancer	0.000605	0.00131	CcSEcCtD
Alosetron—Hypersensitivity—Capecitabine—colon cancer	0.000603	0.00131	CcSEcCtD
Alosetron—Skin disorder—Methotrexate—colon cancer	0.000592	0.00128	CcSEcCtD
Alosetron—Hyperhidrosis—Methotrexate—colon cancer	0.000589	0.00128	CcSEcCtD
Alosetron—Asthenia—Capecitabine—colon cancer	0.000587	0.00127	CcSEcCtD
Alosetron—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000555	0.0012	CcSEcCtD
Alosetron—Fatigue—Methotrexate—colon cancer	0.000525	0.00114	CcSEcCtD
Alosetron—Pain—Methotrexate—colon cancer	0.000521	0.00113	CcSEcCtD
Alosetron—Vomiting—Capecitabine—colon cancer	0.00052	0.00113	CcSEcCtD
Alosetron—Rash—Capecitabine—colon cancer	0.000516	0.00112	CcSEcCtD
Alosetron—Dermatitis—Capecitabine—colon cancer	0.000515	0.00112	CcSEcCtD
Alosetron—Headache—Capecitabine—colon cancer	0.000512	0.00111	CcSEcCtD
Alosetron—Feeling abnormal—Methotrexate—colon cancer	0.000502	0.00109	CcSEcCtD
Alosetron—Nausea—Capecitabine—colon cancer	0.000486	0.00105	CcSEcCtD
Alosetron—Urticaria—Methotrexate—colon cancer	0.000484	0.00105	CcSEcCtD
Alosetron—Hypersensitivity—Methotrexate—colon cancer	0.000449	0.000972	CcSEcCtD
Alosetron—Asthenia—Methotrexate—colon cancer	0.000437	0.000947	CcSEcCtD
Alosetron—Vomiting—Methotrexate—colon cancer	0.000387	0.000839	CcSEcCtD
Alosetron—Rash—Methotrexate—colon cancer	0.000384	0.000832	CcSEcCtD
Alosetron—Dermatitis—Methotrexate—colon cancer	0.000384	0.000831	CcSEcCtD
Alosetron—Headache—Methotrexate—colon cancer	0.000381	0.000826	CcSEcCtD
Alosetron—Nausea—Methotrexate—colon cancer	0.000362	0.000784	CcSEcCtD
